{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T22:49:54Z","timestamp":1771454994956,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The care of psoriatic patients requires a multidisciplinary approach that addresses not only skin involvement but also cardiovascular risk factors. Coordination between dermatology and internal medicine departments, with a specific focus on treatment and long-term follow-up, can substantially improve the course of a disease and its associated complications. Objective: to evaluate the effects of the holistic management of patients with psoriasis by a multidisciplinary team consisting of dermatology and internal medicine specialists. Methods: We conducted an observational, prospective, single-center case\u2013control study between October 2016 and December 2019 in San Jorge University Hospital (Huesca, Spain). Cases included patients undergoing follow-up in the combined dermatology and internal medicine clinic. The control group consisted of an equivalent number of randomly selected, age- and sex-matched patients with moderate-to-severe psoriasis who were seen in the general dermatology department of the same hospital during the same time period. Main outcomes and measures: The primary outcome was the control of psoriatic disease and cardiovascular risk factors such as weight, blood pressure, waist circumference, body mass index (BMI), SCORE index (Systematic Coronary Risk Evaluation), and blood test parameters, as well as diet, physical exercise, and habits such as tobacco and alcohol consumption. To compare data collected over time, data were grouped into three time periods: baseline (t1), intermediate (t2), and final (t3). Results: The case group consisted of 27 patients, and the control group consisted of 25 patients. Multivariate analysis was used to evaluate the relationship between the 10-year risk of experiencing a cardiovascular event (SCORE) and the clinical characteristics and analytical variables of patients with psoriasis and controls (n = 52). The variables that were significantly associated with a higher 10-year risk of experiencing a cardiovascular event were age (OR, 1.33; CI95% 1.21\u20131.50; p &lt; 0.001); smoking (OR, 5.05, CI95% 1.07\u201327.37; p = 0.047); PASI (OR, 7.98, CI95% 2.32\u201335.86; p = 0.003); BSA (OR, 1.22, CI95% 1.01\u20131.49; p = 0.044); and being a control patient (OR, 3.26; CI95% 0.84\u201313.56; p = 0.029). Conclusions: Pharmacological and behavioral interventions carried out as part of the procedure of the multidisciplinary clinic resulted in improvements in the following variables relative to the control group: PASI, BSA, DLQI, PSOLIFE, lipid profile, insulin and HOMA-IR GGT levels, vitamin D levels, and SCORE. These findings indicate the beneficial effect of the multidisciplinary clinic, which reduced the risk of cardiovascular events in psoriatic patients with metabolic comorbidities.<\/jats:p>","DOI":"10.3390\/jcm13082441","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T07:44:09Z","timestamp":1713771849000},"page":"2441","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Impact of Shared Assistance between Dermatology and Internal Medicine on Patients with Psoriasis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2826-7893","authenticated-orcid":false,"given":"Ana Julia","family":"Garc\u00eda-Malinis","sequence":"first","affiliation":[{"name":"Dermatology Unit, San Jorge University Hospital, 22004 Huesca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-2600","authenticated-orcid":false,"given":"Juan Blas","family":"P\u00e9rez-Gilaberte","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miguel Servet University Hospital, 50009 Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0523-2076","authenticated-orcid":false,"given":"Tamara","family":"Gracia-Caza\u00f1a","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, 50009 Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pilar","family":"Gonz\u00e1lez Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, San Jorge University Hospital, 22004 Huesca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Planas Linares","sequence":"additional","affiliation":[{"name":"Dermatology Unit, San Jorge University Hospital, 22004 Huesca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8034-3617","authenticated-orcid":false,"given":"Yolanda","family":"Gilaberte","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, 50009 Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2353\/ajpath.2008.070710","article-title":"Revisiting the Koebner phenomenon: Role of NGF and its receptor system in the pathogenesis of psoriasis","volume":"172","author":"Raychaudhuri","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","unstructured":"WHO (2015, March 13). World Psoriasis Day\u2014Document EB133.R2, Agenda Item 6.2. 30 May 2013. Available online: http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB133\/B133_R2-en.pdf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","first-page":"101","article-title":"Psoriasis-Arthritis Units: Three Years on","volume":"109","year":"2018","journal-title":"Actas Dermosifiliogr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ad.2013.10.009","article-title":"Multidisciplinary psoriasis and psoriatic arthritis unit: Report of 4 years\u2019 experience","volume":"105","author":"Luelmo","year":"2014","journal-title":"Actas Dermosifiliogr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/BOR.0b013e3283031ae0","article-title":"Centers for psoriasis: A comprehensive approach to patient care, education and research","volume":"20","author":"Ritchlin","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaad.2018.12.037","article-title":"All-cause and cause-specific mortality in psoriasis: A systematic review and meta-analysis","volume":"80","author":"Dhana","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_10","first-page":"e201903013","article-title":"Prevalence of ten Immune-mediated inflammatory diseases (IMID) in Spain","volume":"93","author":"Puig","year":"2019","journal-title":"Rev. Esp. Salud Publica"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-0029-1204995","article-title":"Zur Lehre von der neurogenen und der thyreogenen Glykosurie (Schluss aus No. 18.)","volume":"23","author":"Strauss","year":"1897","journal-title":"DMW-Dtsch. Med. Wochenschr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: What is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Karpi\u0144ska-Mirecka, A., Bartosi\u0144ska, J., and Krasowska, D. (2021). The Impact of Hypertension, Diabetes, Lipid Disorders, Overweight\/Obesity and Nicotine Dependence on Health-Related Quality of Life and Psoriasis Severity in Psoriatic Patients Receiving Systemic Conventional and Biological Treatment. Int. J. Environ. Res. Public. Health, 18.","DOI":"10.3390\/ijerph182413167"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The \u201cpsoriatic march\u201d: A concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjd.20517","article-title":"The promise and challenges of cell therapy for psoriasis","volume":"185","author":"Lwin","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000156599","article-title":"Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project","volume":"217","author":"Naldi","year":"2008","journal-title":"Dermatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0300060520964024","article-title":"Impact of smoking on psoriasis risk and treatment efficacy: A meta-analysis","volume":"48","author":"Zhou","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_20","first-page":"1","article-title":"En nombre de la Sociedad Espa\u00f1ola de Arteriosclerosis; Miembros de la Sociedad Espa\u00f1ola de Arteriosclerosis Standards for global cardiovascular risk management arteriosclerosis","volume":"31","author":"Mostaza","year":"2019","journal-title":"Clin. Investig. Arterioscler. Publicacion Soc. Espanola Arterioscler."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00403-011-1172-6","article-title":"Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic","volume":"304","author":"Velez","year":"2012","journal-title":"Arch. Dermatol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/CM9.0000000000001588","article-title":"A multidisciplinary team for the diagnosis and management of psoriatic arthritis","volume":"134","author":"Zheng","year":"2021","journal-title":"Chin. Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/msc.1690","article-title":"The role of the multidisciplinary team in the management of psoriatic arthritis","volume":"20","author":"Jadon","year":"2022","journal-title":"Musculoskelet. Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ad.2023.09.001","article-title":"Selection of Quality Indicators for the Certification of Psoriasis Units: The CUDERMA Project Delphi Consensus Study","volume":"114","author":"Gilaberte","year":"2023","journal-title":"Actas Dermosifiliogr."},{"key":"ref_25","unstructured":"NICE (2023, June 01). Psoriasis: Assessment and Management. NICE Clinical Guideline. In Excellence NNIoHaC: Niceorguk\/Guidance\/cg153, 2012 (Updated 2017). Disponible. Available online: https:\/\/www.nice.org.uk\/guidance\/cg153."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bjd.21718","article-title":"Alcohol consumption and smoking in relation to psoriasis: A Mendelian randomization study","volume":"187","author":"Wei","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.26444\/aaem\/112107","article-title":"Environmental risk factors and epigenetic alternations in psoriasis","volume":"27","author":"Roszkiewicz","year":"2020","journal-title":"Ann. Agric. Environ. Med. AAEM"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e15685","DOI":"10.1111\/dth.15685","article-title":"The role of lifestyle and nutrition in psoriasis: Current status of knowledge and interventions","volume":"35","author":"Musumeci","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Huang, S., and Bai, Y. (2023). Knowledge Mapping and Research Hotspots of Comorbidities in Psoriasis: A Bibliometric Analysis from 2004 to 2022. Med. Kaunas Lith., 59.","DOI":"10.3390\/medicina59020393"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"103169","DOI":"10.1016\/j.autrev.2022.103169","article-title":"Psoriasis: Interplay between dysbiosis and host immune system","volume":"21","author":"Kapoor","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Karampinis, E., Papadopoulou, M.-M., Chaidaki, K., Georgopoulou, K.-E., Magaliou, S., Roussaki Schulze, A.V., Bogdanos, D.P., and Zafiriou, E. (2024). Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters. Vaccines, 12.","DOI":"10.3390\/vaccines12020178"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ije\/dyz212","article-title":"Impact of follow-up time and analytical approaches to account for reverse causality on the association between physical activity and health outcomes in UK Biobank","volume":"49","author":"Strain","year":"2020","journal-title":"Int. J. Epidemiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/8\/2441\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:32:13Z","timestamp":1760106733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/8\/2441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["jcm13082441"],"URL":"https:\/\/doi.org\/10.3390\/jcm13082441","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]}}}